Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R E Kates

Showing results (1-10 of 101) with videos related to

Pageof 11
Sort By:
The American Journal of Cardiology|September 22, 1983
Plasma level monitoring of antiarrhythmic drugsR E Kates
Rational Drug Therapy|May 1, 1986
Metabolites of antiarrhythmic drugs: are they clinically important?R E Kates
Therapeutic Drug Monitoring|January 1, 1980
Therapeutic monitoring of antiarrhythmic drugsR E Kates
Drugs|February 1, 1983
Calcium antagonists. Pharmacokinetic propertiesR E Kates
Journal of Medicine|January 1, 1977
Absorption kinetics of sublingually administered propranololR E Kates
Giornale Italiano Di Cardiologia|August 1, 1986
The importance of pharmacokinetics and pharmacodynamics in the clinical evaluation of antiarrhythmic drugsR E Kates
Annals of the New York Academy of Sciences|January 1, 1984
Metabolites of cardiac antiarrhythmic drugs: their clinical roleR E Kates
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1980
Phenytoin-induced changes in quinidine and 3-hydroxyquinidine pharmacokinetics in conscious dogsP Jaillon, R E Kates
Journal of Chromatography|August 10, 1984
Simple and rapid high-performance liquid chromatographic analysis of cyclosporine in human blood and serumR E Kates, R Latini
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1980
A model to describe myocardial drug disposition in the dogR E Kates, P Jaillon
Pageof 11

Showing results (1-10 of 101) with videos related to

Sort By:
Pageof 11
The American Journal of Cardiology|September 22, 1983
Plasma level monitoring of antiarrhythmic drugsR E Kates
Rational Drug Therapy|May 1, 1986
Metabolites of antiarrhythmic drugs: are they clinically important?R E Kates
Therapeutic Drug Monitoring|January 1, 1980
Therapeutic monitoring of antiarrhythmic drugsR E Kates
Drugs|February 1, 1983
Calcium antagonists. Pharmacokinetic propertiesR E Kates
Journal of Medicine|January 1, 1977
Absorption kinetics of sublingually administered propranololR E Kates
Giornale Italiano Di Cardiologia|August 1, 1986
The importance of pharmacokinetics and pharmacodynamics in the clinical evaluation of antiarrhythmic drugsR E Kates
Annals of the New York Academy of Sciences|January 1, 1984
Metabolites of cardiac antiarrhythmic drugs: their clinical roleR E Kates
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1980
Phenytoin-induced changes in quinidine and 3-hydroxyquinidine pharmacokinetics in conscious dogsP Jaillon, R E Kates
Journal of Chromatography|August 10, 1984
Simple and rapid high-performance liquid chromatographic analysis of cyclosporine in human blood and serumR E Kates, R Latini
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1980
A model to describe myocardial drug disposition in the dogR E Kates, P Jaillon
Pageof 11